Ultralife Corporation
ULBI
$7.79
$0.141.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -508.36% | -238.79% | -52.87% | 861.34% | -24.81% |
| Total Depreciation and Amortization | -7.89% | 0.07% | 4.65% | 14.93% | 18.61% |
| Total Amortization of Deferred Charges | 0.00% | -2.94% | 4.62% | 38.30% | 291.67% |
| Total Other Non-Cash Items | 3,622.46% | -156.21% | -16.07% | 69.08% | 276.09% |
| Change in Net Operating Assets | -1,144.98% | -93.21% | 713.35% | -139.22% | -62.24% |
| Cash from Operations | 652.02% | -96.66% | 76.22% | 10.57% | -35.82% |
| Capital Expenditure | 11.36% | 9.55% | -22.91% | -47.69% | -2.02% |
| Sale of Property, Plant, and Equipment | -200.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.60% | 9.91% | -22.91% | 98.16% | -8,086.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.15% | 74.40% | -291.27% | 91.45% | -99.23% |
| Issuance of Common Stock | -100.00% | -39.34% | -- | -- | 62.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -1,847.06% |
| Cash from Financing | -5.53% | 75.44% | -285.88% | -101.50% | 1,220.43% |
| Foreign Exchange rate Adjustments | 171.31% | -723.68% | -51.90% | 538.89% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.06% | -175.65% | 19.14% | 2,231.25% | -4.76% |